Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model

por Hu, Hai-Jun, Liang, Xiu, Li, Hai-Lang, Wang, Huai-Yuan, Gu, Jin-Fa, Sun, Lan-Ying, Xiao, Jing, Hu, Jin-Qing, Ni, Ai-Min, Liu, Xin-Yuan
Publicado 2021

Investigation and influencing factors about well-being level of elderly chronic patients during COVID-19 postpandemic period in Beijing

por Wu, Chen, Liu, Yu-Xuan, Liu, Tie-Jun, Yan, Xu-Ling, Zhao, Yu-Xi, Zeng, Hong, Zhou, Tian, Rao, Ping, Sun, Lan-Ying, Jiao, Yang, Xi, Jia-Ning
Publicado 2022

HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy

por Xu, Hai-Neng, Huang, Wei-Dan, Cai, Ying, Ding, Miao, Gu, Jin-Fa, Wei, Na, Sun, Lan-Ying, Cao, Xin, Li, Hua-Guang, Zhang, Kang-Jian, Liu, Xin-Ran, Liu, Xin-Yuan
Publicado 2011

The armed oncolytic adenovirus ZD55-IL-24 eradicates melanoma by turning the tumor cells from the self-state into the nonself-state besides direct killing

por Hu, Hai-Jun, Liang, Xiu, Li, Hai-Lang, Du, Chun-Ming, Hao, Jia-Li, Wang, Huai-Yuan, Gu, Jin-Fa, Ni, Ai-Min, Sun, Lan-Ying, Xiao, Jing, Hu, Jin-Qing, Yuan, Hao, Dai, Yan-Song, Jin, Xiao-Ting, Zhang, Kang-Jian, Liu, Xin-Yuan
Publicado 2020